The influence of neuroinflammation in Autism Spectrum Disorder
Abstract Autism Spectrum Disorder (ASD) is a neurodevelopmental disorder characterised
by deficits in social communication and restricted or repetitive behaviours. The clinical …
by deficits in social communication and restricted or repetitive behaviours. The clinical …
Cytokines and brain excitability
MA Galic, K Riazi, QJ Pittman - Frontiers in neuroendocrinology, 2012 - Elsevier
Cytokines are molecules secreted by peripheral immune cells, microglia, astrocytes and
neurons in the central nervous system. Peripheral or central inflammation is characterized …
neurons in the central nervous system. Peripheral or central inflammation is characterized …
PDGFRβ cells rapidly relay inflammatory signal from the circulatory system to neurons via chemokine CCL2
Acute infection, if not kept in check, can lead to systemic inflammatory responses in the
brain. Here, we show that within 2 hr of systemic inflammation, PDGFRβ mural cells of blood …
brain. Here, we show that within 2 hr of systemic inflammation, PDGFRβ mural cells of blood …
A systematic analysis of the peripheral and CNS effects of systemic LPS, IL-1β, TNF-α and IL-6 challenges in C57BL/6 mice
DT Skelly, E Hennessy, MA Dansereau… - PloS one, 2013 - journals.plos.org
It is increasingly clear that systemic inflammation has both adaptive and deleterious effects
on the brain. However, detailed comparisons of brain effects of systemic challenges with …
on the brain. However, detailed comparisons of brain effects of systemic challenges with …
Inflammatory cytokines: potential biomarkers of immunologic dysfunction in autism spectrum disorders
N Xu, X Li, Y Zhong - Mediators of inflammation, 2015 - Wiley Online Library
Autism is a disorder of neurobiological origin characterized by problems in communication
and social skills and repetitive behavior. After more than six decades of research, the …
and social skills and repetitive behavior. After more than six decades of research, the …
Mesenchymal stem cells and conditioned media in the treatment of multiple sclerosis patients: Clinical, ophthalmological and radiological assessments of safety and …
Aims This open‐label prospective phase I/II a clinical study used autologous bone marrow‐
derived mesenchymal stromal cells (BM‐MSC s) followed by mesenchymal stromal cells …
derived mesenchymal stromal cells (BM‐MSC s) followed by mesenchymal stromal cells …
Dual CCR5/CCR2 targeting: opportunities for the cure of complex disorders
L Fantuzzi, M Tagliamonte, MC Gauzzi… - Cellular and molecular life …, 2019 - Springer
The chemokine system mediates acute inflammation by driving leukocyte migration to
damaged or infected tissues. However, elevated expression of chemokines and their …
damaged or infected tissues. However, elevated expression of chemokines and their …
Toward identifying key mechanisms of progression in multiple sclerosis
L Husseini, A Geladaris, MS Weber - Trends in Neurosciences, 2024 - cell.com
A major therapeutic goal in the treatment of multiple sclerosis (MS) is to prevent the
accumulation of disability over an often decades-long disease course. Disability progression …
accumulation of disability over an often decades-long disease course. Disability progression …
Immune treatments for alcohol use disorder: A translational framework
While the immune system is essential for survival, an excessive or prolonged inflammatory
response, such as that resulting from sustained heavy alcohol use, can damage the host …
response, such as that resulting from sustained heavy alcohol use, can damage the host …
CCL2/MCP-1 modulation of microglial activation and proliferation
AE Hinojosa, B Garcia-Bueno, JC Leza… - Journal of …, 2011 - Springer
Background Monocyte chemoattractant protein (CCL2/MCP-1) is a chemokine that attracts
cells involved in the immune/inflammatory response. As microglia are one of the main cell …
cells involved in the immune/inflammatory response. As microglia are one of the main cell …